HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N-phthaloyl-glycine-hydroxamic acid as serum iron chelator in rats.

Abstract
The aim of this study was to investigate the activity of N-phthaloyl-glycine-hydroxamic acid (Phth-Gly-HA) as a new iron chelator in vivo to be used in iron overload diseases. After intraperitoneal application of Phth-Gly-HA to male rats (1 mg kg(-1) body mass) once a day for seven days, iron serum level decreased by 21%, whereas the iron value dropped by 32% in female rats (1.5 mg kg(-1) body mass). The results indicate that the tested substance has the ability to bind serum iron by complexation. Besides transferrin iron release, mobilization of ferritin iron is also possible.
AuthorsJulija Matijević-Sosa, Ita Samarzija, Lorena Honović, Blazenka Jurisić
JournalActa pharmaceutica (Zagreb, Croatia) (Acta Pharm) Vol. 58 Issue 2 Pg. 231-6 (Jun 2008) ISSN: 1330-0075 [Print] Poland
PMID18515233 (Publication Type: Journal Article)
Chemical References
  • Hydroxamic Acids
  • Iron Chelating Agents
  • Transferrin
  • N-phthalylglycine
  • Ferritins
  • Iron
  • Glycine
Topics
  • Animals
  • Drug Administration Schedule
  • Female
  • Ferritins (blood)
  • Glycine (administration & dosage, analogs & derivatives, pharmacology)
  • Hydroxamic Acids (administration & dosage, pharmacology)
  • Injections, Intraperitoneal
  • Iron (blood)
  • Iron Chelating Agents (administration & dosage, pharmacology)
  • Iron Overload (drug therapy, metabolism)
  • Male
  • Rats
  • Rats, Wistar
  • Transferrin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: